Particle.news
Immunotherapy Chemotherapy Targeted Therapy CAR-T Cell Therapy Ferroptosis Leukemia Effectiveness of Surgery and Chemotherapy Preventative Chemotherapy Adjuvant Therapy Royal Family Cancer Treatment Therapeutic Targeting of lncRNAs Immunotherapy Strategies Immune Checkpoint Inhibitors Diet and Cancer Therapy Hyperthermia Leukaemia Treatment Resistance Drug Resistance Oncolytic Viruses Oncolytic Virus Therapy Hydrogel-based Therapies Bacterial Therapy Vaccines Bacterial-Viral Therapy Glioblastoma Boron Neutron Capture Therapy Aspirin Drug Development Aspirin Therapy Radiation Therapy Head and Neck Cancer CAR T Cell Therapy Targeted Therapies Tumor Cell Death Immune System Modulation Haematological Cancers AI in Cancer Research Nanorobots Surgical Imaging Prostate Cancer Public Figures with Cancer Radioconjugates
The Nature Materials study reports week-long, tumor-localized IL-12 delivery that overcame immunotherapy resistance in metastatic models.
